| Window | Theses | Resolved | Wins | Win rate | Avg return | Median return |
|---|---|---|---|---|---|---|
| 1d | 3 | 3 | 3 | 100% | +1.4% | +1.7% |
| 3d | 3 | 3 | 3 | 100% | +1.4% | +1.7% |
| 1w | 3 | 3 | 2 | 67% | +0.6% | +0.9% |
| 1m | 3 | 3 | 1 | 33% | -2.8% | -6.5% |
| 3m | 3 | 3 | 3 | 100% | +15.7% | +9.0% |
| 6m | 3 | 3 | 2 | 67% | +10.7% | +16.0% |
| 1y | 3 | 3 | 3 | 100% | +30.8% | +33.3% |
Past performance does not predict future results. Informational only, not investment advice.
TD Bank trades justifiably above book value with a strong fundamental position post-money laundering fine. The bank is positioned to benefit from lower interest rates and conservative political tailwinds in the US and Canada.
Ecopetrol trades at a compelling sub-5 P/E with strong operating margins and a robust balance sheet. The 18% dividend yield is attractive despite geopolitical risk in Colombia.
Pfizer's forward P/E of 18 is reasonable given its patent portfolio, cash generation, and ability to pursue new opportunities. The current dividend yield is sustainable and the company is fundamentally sound.
End of results.